Hims & Hers 与礼来达成GLP-1协议，其股价正在上涨。根据协议，Hims表示将停止复配Zepbound等GLP-1药物。引述“Hims表示，未来将不再复配Zepbound等GLP-1药物。”— Hims & Hers来源Hims & Hers struck a GLP-1 deal with Lilly. Its stock is rallying.MarketWatch